We are live on ! Find out more
MAM

Martingale Asset Management Portfolio holdings

AUM $3.99B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+22.65%
3 Year Est. Return
+77.2%
5 Year Est. Return
+114.11%
10 Year Est. Return
+351.19%
AUM
$5.19B
AUM Growth
+$56.7M
Cap. Flow
+$1.18M
Cap. Flow %
0.02%
Top 10 Hldgs %
12.17%
Holding
912
New
89
Increased
357
Reduced
289
Closed
97

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$25.7M
2
DRI icon
Darden Restaurants
DRI
+$24.4M
3
AXP icon
American Express
AXP
+$21.1M
4
NOC icon
Northrop Grumman
NOC
+$19.3M
5
JPM icon
JPMorgan Chase
JPM
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 17.73%
3 Financials 15.37%
4 Consumer Staples 12.75%
5 Industrials 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYF icon
776
Synchrony
SYF
$25.6B
$207K ﹤0.01%
+7,122
New +$239K
NVDA icon
777
NVIDIA
NVDA
$5.3T
$207K ﹤0.01%
+7,450
New +$161K
MFA
778
MFA Financial
MFA
$919M
$205K ﹤0.01%
+20,636
New +$219K
DGX icon
779
Quest Diagnostics
DGX
$26.3B
$202K ﹤0.01%
+1,426
New +$204K
ALXO icon
780
ALX Oncology
ALXO
$284M
$202K ﹤0.01%
44,609
MDXG icon
781
MiMedx Group
MDXG
$609M
$201K ﹤0.01%
58,900
VHI icon
782
Valhi
VHI
$453M
$195K ﹤0.01%
11,229
+1
+0% +$23
ACAD icon
783
Acadia Pharmaceuticals
ACAD
$4.9B
$195K ﹤0.01%
10,372
-2
-0% -$38
TVRD
784
Tvardi Therapeutics
TVRD
$23.1M
$192K ﹤0.01%
1,084
AFCG
785
AFC Gamma
AFCG
$63M
$191K ﹤0.01%
22,989
+1,330
+6% +$13.5K
AURA icon
786
Aura Biosciences
AURA
$799M
$189K ﹤0.01%
+20,354
New +$211K
EGAN icon
787
eGain
EGAN
$202M
$189K ﹤0.01%
24,871
+6
+0% +$52
SANA icon
788
Sana Biotechnology
SANA
$949M
$186K ﹤0.01%
56,915
NABL icon
789
N-able
NABL
$917M
$173K ﹤0.01%
13,100
-29,447
-69% -$325K
IPSC icon
790
Century Therapeutics
IPSC
$343M
$171K ﹤0.01%
+49,151
New +$216K
RXRX icon
791
Recursion Pharmaceuticals
RXRX
$1.69B
$169K ﹤0.01%
25,400
+200
+0.8% +$1.59K
CXW icon
792
CoreCivic
CXW
$3.19B
$167K ﹤0.01%
+18,200
New +$187K
QUAD icon
793
Quad
QUAD
$515M
$154K ﹤0.01%
+35,867
New +$158K
EDIT icon
794
Editas Medicine
EDIT
$445M
$148K ﹤0.01%
20,420
+4,102
+25% +$36.5K
GWRS icon
795
Global Water Resources
GWRS
$215M
$142K ﹤0.01%
11,411
CBAN icon
796
Colony Bankcorp
CBAN
$468M
$137K ﹤0.01%
13,415
+1,200
+10% +$14.6K
KNTE
797
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$136K ﹤0.01%
21,822
-700
-3% -$4.26K
AVIR icon
798
Atea Pharmaceuticals
AVIR
$399M
$134K ﹤0.01%
40,100
-176,185
-81% -$715K
HTBK
799
DELISTED
Heritage Commerce
HTBK
$133K ﹤0.01%
+15,945
New +$183K
CCCC icon
800
C4 Therapeutics
CCCC
$402M
$124K ﹤0.01%
39,420
+6,724
+21% +$39.6K

Similar funds

Martingale Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Martingale Asset Management held 912 positions worth $5.19B, up 1.1% from $5.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Martingale Asset Management's Q1 2023 filing shows 89 new, 357 increased, 289 reduced and 97 closed positions. Its largest new stake was Bank of New York Mellon: 210,130 shares worth $9.55M. The largest sale was Apple, an estimated $22.6M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Martingale Asset Management's largest Q1 2023 buy was Bank of New York Mellon: 210,130 shares worth $9.55M.
  • Martingale Asset Management added most to Chevron in Q1 2023, an estimated $25.7M increase.
  • Martingale Asset Management's biggest Q1 2023 reduction was Apple, cutting an estimated $22.6M.
  • Martingale Asset Management fully exited Essex Property Trust in Q1 2023, selling an estimated $13.1M.
  • Martingale Asset Management's ten largest holdings make up 12% of its $5.19B portfolio in Q1 2023.
  • Martingale Asset Management opened 89 new positions and closed 97 in Q1 2023.
  • Martingale Asset Management's portfolio value rose 1.1% quarter-over-quarter to $5.19B.

Based on Martingale Asset Management's 13F filing for Q1 2023, filed 12 May 2023.